You are here : Home / Technology / Assay format

Assay format

HTRF®, a technological platform for your own assay development

HTRF was originally created as an immunoassay technology nearly two decades ago, and continues to offer one of the most effective and flexible solutions in the diagnostic field today. Its versatility has led to the optimization of numerous assay configurations for drug research, from the most basic biochemical tests to more sophisticated cell-based assays. HTRF has become a reference technology for researchers who wish to transition from conventional assays such as Western Blot, ELISA, or bead-based technologies, and successfully convert to fast and cost-effective mix & measure assay formats.

Cisbio Bioassays presents a wide selection of cell-based assays developed with HTRF® technology. HTRF® assays listed in this section were developed to facilitate working with whole cells, thereby enabling functional assays to be run under physiological conditions. For HTS purposes, HTRF® cell-based assay protocols have been streamlined to single-plate processes from cell culture to assay readout. Cells remain alive until the final detection step.

Features

  • Truly homogeneous functional assays
  • Mix-and-read protocol
  • Flexible assay procedures:
    -Assessment of secreted molecules via their quantification in cell culture medium, even when complemented with FCS
    -Simultaneous cell lysis and detection to assess intracellular messengers using a single-plate protocol
  • Time-resolved detection to correct for prompt background fluorescence
  • Ratiometric correction to avoid medium interference

Example of an HTRF® cell-based assay:

These assays are designed to assess molecules that are large enough to encompass two distinct binding sites for two antibodies (Ab). As shown here, HTRF® sandwich assays use two antibodies coupled respectively to Eu3+ or Lumi4®-Tb cryptate and to an HTRF® acceptor (i.e. XL665 or d2). The two conjugates bind to the antigen when present in the sample, thereby generating FRET.

 

The following list shows a selection of assays based on an immunometric format (sandwich assays)

Assay
Cellular kinases
(pErk, pAkt, etc.)
Cytokines
(h&m TNFa, IL2, IL8, etc.)
Apo A1 and B
Insulin
Amyloid B1-40
Human IgG Kappa and Lambda

Signal intensity is proportional to the number of Ab-Ag complexes formed, and therefore to Ag concentration. The specific signal modulates positively in proportion to Ag concentration.

These assays are designed to assess molecules that are too small to allow the binding of two antibodies. The two assay components used here consist of an acceptor conjugate generally made of purified antigen, and its respective Ab coupled to Eu3+ or Lumi4®-Tb cryptate. The Ag present in the sample competes with the binding between the two conjugates and thereby prevents FRET from occurring.

 

The following list shows a selection of assays based on an immunocompetitive format

Assay
cAMP
IP-One
cGMP
Histamine
PGE2
LTB4
LTC4
GST and 6HIS check kits
Assay
Estradiol
Glucagon
Cortisol
Aldosterone
Transcreener ADP
Total human igG
CD16a
SIRT1

FRET intensity decreases with the amount of dissociated Ab-Ag complexes. The specific signal modulates nega- tively, is therefore inversely proportional to Ag concentration.

 





© 2012 Cisbio.com - All Rights Reserved